Home: PCU
5|2003: Michael K Brawer, MD: Select publications
Select publications
Publications discussed by Dr Brawer
The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial. Br J Urol 1997;79(2):235-46. Abstract
Bolla M et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997;337:295-300. Abstract
Bolla M et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet 2002;360(9327):103-6. Abstract
Byar DP, Corle DK. Hormone therapy for prostate cancer: Results of the Veterans Administration Cooperative Urological Research Group studies. NCI Monogr 1988;(7):165-70. Abstract
de Koning HJ et al; European Randomized Screening for Prostate Cancer (ERSPC) Trial; International Prostate Cancer Screening Trials Evaluation Group. Large-scale randomized prostate cancer screening trials: Program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002;97(2):237-44. Abstract
Holmberg L et al; Scandinavian Prostatic Cancer Group Study Number 4. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347(11):781-9. Abstract
Messing EM et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 1999;341:1781-8. Abstract
See WA et al; Casodex Early Prostate Cancer Trialist Group. Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the early prostate cancer program. J Urol 2002;168(2):429-35. Erratum in: J Urol 2002;168(6):2558. J Urol 2002;168;4(Pt 1):1510. Abstract
Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial (PIVOT). Oncology (Huntingt) 1997;11(8):1133-9; discussion 1139-40, 1143. Abstract
Vancouver experience with intermittent androgen suppression
Bruchovsky N et al. Intermittent androgen suppression for prostate cancer: Canadian Prospective Trial and related observations. Mol Urol 2000;4(3):191-9; discussion 201. Abstract
Gleave M et al. Intermittent androgen suppression for prostate cancer: Rationale and clinical experience. Prostate Cancer Prostatic Dis 1998;1(6):289-296. Abstract
Gleave M et al. Intermittent androgen suppression for prostate cancer: Rationale and clinical experience. Eur Urol 1998;34(Suppl 3):37-41. Abstract
Goldenberg SL et al. Clinical experience with intermittent androgen suppression in prostate cancer: Minimum of 3 years' follow-up. Mol Urol 1999;3(3):287-292. Abstract
Hurtado-Coll A et al. Intermittent androgen suppression in prostate cancer: The Canadian experience. Urology 2002;60(3 Suppl 1):52-6; discussion 56. Abstract
Pether M et al. Intermittent androgen suppression in prostate cancer: An update of the Vancouver experience. Can J Urol 2003;10(2):1809-14. Abstract
|
